Role of Prolyl Hydroxylation in Oncogenically Stabilized Hypoxia-inducible Factor-1α
Open accessThe DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Abstract
Stabilization of the hypoxia-inducible factor-1 (HIF-1) protein is essential for its role as a regulator of gene expression under low oxygen conditions. Here, employing a novel hydroxylation-specific antibody, we directly show that proline 564 of HIF-1alpha and proline 531 of HIF-2alpha are hydroxylated under normoxia. Importantly, HIF-1alpha Pro-564 and HIF-2alpha Pro-531 hydroxylation is diminished with the treatment of hypoxia, cobalt chloride, desferrioxamine, or dimethyloxalyglycine, regardless of the E3 ubiquitin ligase activity of the von Hippel-Lindau (VHL) tumor suppressor gene. Furthermore, in VHL-deficient cells, HIF-1alpha Pro-564 and HIF-2alpha Pro-531 had detectable amounts of hydroxylation following transition to hypoxia, indicating that the post-translational modification is not reversible. The introduction of v-Src or RasV12 oncogenes resulted in the stabilization of normoxic HIF-1alpha and the loss of hydroxylated Pro-564, demonstrating that oncogene-induced stabilization of HIF-1alpha is signaled through the inhibition of prolyl hydroxylation. Conversely, a constitutively active Akt oncogene stabilized HIF-1alpha under normoxia independently of prolyl hydroxylation, suggesting an alternative mechanism for HIF-1alpha stabilization. Thus, these results indicate distinct pathways for HIF-1alpha stabilization by different oncogenes. More importantly, these findings link oncogenesis with normoxic HIF-1alpha expression through prolyl hydroxylation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Tissue culture cells, particularly cells with activated oncogenic pathways, can accumulate HIFα in a nonhydroxylated form under well-oxygenated conditions (Chan et al., 2002).”
From Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. (2008) · cites this paper as Chan et al., 2002
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Semenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
Self-citationOhh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L. (2002) · Science · doi:10.1126/science.1068592 · Cited by 1,558
Oxygen sensing and molecular adaptation to hypoxia
Bunn, H. F., & Poyton, R. O. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.3.839 · Cited by 1,172
Research works printed but not linked: 3
- Semenza, G. L., and Wang, G. L. (1992) Mol. Cell. Biol. 12, 5447-5454
- Jiang, B. H., Agani, F., Passaniti, A., and Semenza, G. L. (1997) Cancer Res. 57, 5328 -5335
- Ryan, H. E., Poloni, M., McNulty, W., Elson, D., Gassmann, M., Arbeit, J. M., and Johnson, R. S. (2000) Cancer Res. 60, 4010 -4015
Cited by
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
“VHL then recognizes the modified HIF-a proteins, acts as an E3-type of ubiquitin ligase, and along with elongins B and C is responsible for the polyubiquitination of HIF-as and their proteosomal degradation (Bruick and McKnight, 2001; Chan et al., 2002; Ivan et al., 2001; Jaakkola et al., 2001).”
BackgroundInfluentialSelf-citationOxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068
“Using hydroxylation-specific antibodies, it has been shown that the HIF1α CODDD is not always fully hydroxylated in such cell”
MethodHypoxia, HIF1 and glucose metabolism in the solid tumour
Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707
Self-citationBerra, E., Benizri, E., Ginouvès, A., Volmat, V., Roux, D., & Pouysségur, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg392 · Cited by 1,348
Jung, Y.-J., Isaacs, J. S., Lee, S., Trepel, J., & Neckers, L. (2003) · The FASEB Journal · doi:10.1096/fj.03-0329fje · Cited by 679
“Although the precise mechanism for HIF-1α up-regulation is unclear, reports show that oncogenic signaling molecules can attenuate the sensitivity of HIF-1α to VHL under normoxic conditions (57).”
BackgroundHIF-1 as a target for drug development
Giaccia, A., Siim, B. G., & Johnson, R. S. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1199 · Cited by 631
Self-citationJunD Reduces Tumor Angiogenesis by Protecting Cells from Oxidative Stress
Gerald, D., Berra, E., Frapart, Y. M., Chan, D. A., Giaccia, A. J., Mansuy, D., Pouysségur, J., Yaniv, M., & Mechta-Grigoriou, F. (2004) · Cell · doi:10.1016/j.cell.2004.08.025 · Cited by 588
Self-citationLand, S. C., & Tee, A. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611782200 · Cited by 507
Proline hydroxylation and gene expression
Kaelin, W. G. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133142 · Cited by 468
Hypoxic gene expression and metastasis
Le, Q.-T., Denko, N. C., & Giaccia, A. J. (2004) · Cancer and Metastasis Reviews · doi:10.1023/b:canc.0000031768.89246.d7 · Cited by 468
Self-citationRegulation of angiogenesis by hypoxia-inducible factor 1
Hirota, K., & Semenza, G. L. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.12.003 · Cited by 464
A hitchhiker's guide to the cullin ubiquitin ligases: SCF and its kin
Willems, A. R., Schwab, M., & Tyers, M. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.09.027 · Cited by 464
Bruick, R. K. (2003) · Genes & Development · doi:10.1101/gad.1145503 · Cited by 440
“Later models emphasized the role of signaling pathways that mediate HIF regulation through changes in the phosphorylation and/or redox state of HIF- (Salceda and Caro 1997; Chandel et al. 2000).”
BackgroundNitric Oxide Impairs Normoxic Degradation of HIF-1α by Inhibition of Prolyl Hydroxylases
Metzen, E., Zhou, J., Jelkmann, W., Fandrey, J., & Brüne, B. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-12-0791 · Cited by 414
“Using a hydroxyproline-specific HIF- antibody, it has been demonstrated very recently that oncogenes such as v-Src and RasV12 stabilize HIF-1 in normoxia by attenuating prolyl hydroxylation (Chan et al., 2002).”
BackgroundRegulation of Osteogenesis-Angiogenesis Coupling by HIFs and VEGF
Schipani, E., Maes, C., Carmeliet, G., & Semenza, G. L. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090602 · Cited by 406
MARXSEN, J. H., STENGEL, P., DOEGE, K., HEIKKINEN, P., JOKILEHTO, T., WAGNER, T., JELKMANN, W., JAAKKOLA, P., & METZEN, E. (2004) · Biochemical Journal · doi:10.1042/bj20040620 · Cited by 386
Gray, M. J., Zhang, J., Ellis, L. M., Semenza, G. L., Evans, D. B., Watowich, S. S., & Gallick, G. E. (2005) · Oncogene · doi:10.1038/sj.onc.1208513 · Cited by 372
“Activated Src (either v-Src or Src with activating mutations) has been implicated in both HIF-1a stabilization and increased translation depending on the model system examined (Jiang et al., 1997; Chan et al., 2002; Karni et al., 2002).”
BackgroundInfluentialHypoxia, inflammation, and the tumor microenvironment in metastatic disease
Finger, E. C., & Giaccia, A. J. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9224-5 · Cited by 370
Self-citationTargeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases
Eltzschig, H. K., Bratton, D. L., & Colgan, S. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4422 · Cited by 366
Karve, T. M., & Cheema, A. K. (2011) · Journal of Amino Acids · doi:10.4061/2011/207691 · Cited by 364
“Further, proline hydroxylation of HIF similar to that under normoxic conditions was shown to be protumorigenic [54, 55].”
BackgroundProspective Trial of a Pediatric Ventricular Assist Device
Olesen, J. B., Gislason, H., & Torp-Pedersen, C. T. (2012) · Cited by 357
(2003) · PubMed · Cited by 350
Signalling hypoxia by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.111 · Cited by 341
Pan, Y., Mansfield, K. D., Bertozzi, C. C., Rudenko, V., Chan, D. A., Giaccia, A. J., & Simon, M. C. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01223-06 · Cited by 332
“Anti-hydroxy-HIF-1 antibody was generated as previously described ( 9 ).”
MethodSelf-citationInvestigating hypoxic tumor physiology through gene expression patterns
Denko, N. C., Fontana, L. A., Hudson, K. M., Sutphin, P. D., Raychaudhuri, S., Altman, R., & Giaccia, A. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206703 · Cited by 305
“Under hypoxia, HIF-1a is not hydroxylated (Chan et al., 2002), does not bind to VHL, and becomes stabilized.”
BackgroundSelf-citationHypoxia-driven pathways in bone development, regeneration and disease
Maes, C., Carmeliet, G., & Schipani, E. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.36 · Cited by 300
Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression
Kietzmann, T., & Görlach, A. (2005) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2005.03.010 · Cited by 295
The role of vascular endothelial growth factor in ossification
Yang, Y.-Q., Tan, Y.-Y., Wong, R., Wenden, A., Zhang, L.-K., & Rabie, A. B. M. (2012) · International Journal of Oral Science · doi:10.1038/ijos.2012.33 · Cited by 295
Hypoxia Up-regulates Prolyl Hydroxylase Activity
D'Angelo, G., Duplan, E., Boyer, N., Vigne, P., & Frelin, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302244200 · Cited by 285
Negative and positive regulation of HIF-1: A complex network
Bárdos, J. I., & Ashcroft, M. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.05.001 · Cited by 285
Hammond, E. M., Dorie, M. J., & Giaccia, A. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212360200 · Cited by 284
Self-citationRNA-Binding Proteins HuR and PTB Promote the Translation of Hypoxia-Inducible Factor 1α
Galbán, S., Kuwano, Y., Pullmann, R., Martindale, J. L., Kim, H. H., Lal, A., Abdelmohsen, K., Yang, X., Dang, Y., Liu, J. O., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00973-07 · Cited by 279
“CoCl2 treatment can induce HIF-1 protein levels through its inhibitory effect on prolyl hydroxylases and thereby block the proteasome-dependent degradation of HIF-1 (7, 13, 61).”
BackgroundHypoxia, gene expression, and metastasis
Chan, D. A., & Giaccia, A. J. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9063-1 · Cited by 276
Self-citationMicroenvironment and tumor cell plasticity: An easy way out
Taddei, M. L., Giannoni, E., Comito, G., & Chiarugi, P. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.042 · Cited by 264
“PHD3 [60].”
Review: Hypoxia-Inducible Factor-1 (HIF-1): A Novel Transcription Factor in Immune Reactions
Hellwig-Bürgel, T., Stiehl, D. P., Wagner, A. E., Metzen, E., & Jelkmann, W. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.297 · Cited by 254
Hypoxia-Inducible Factor-1α and the Glycolytic Phenotype in Tumors
Robey, I. F., Lien, A. D., Welsh, S. J., Baggett, B. K., & Gillies, R. J. (2005) · Neoplasia · doi:10.1593/neo.04430 · Cited by 251
“HIF-1a accumulation could also occur by Ras, Src, and/or Akt oncogene expression, leading to inhibition of degradation or enhanced synthesis [33].”
BackgroundThe hypoxia-inducible factors: key transcriptional regulators of hypoxic responses
Bracken, C. P., Whitelaw, M. L., & Peet, D. J. (2003) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-2370-y · Cited by 251
A Molecule Targeting VHL-Deficient Renal Cell Carcinoma that Induces Autophagy
Turcotte, S., Chan, D. A., Sutphin, P. D., Hay, M. P., Denny, W. A., & Giaccia, A. J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.004 · Cited by 251
“Under hypoxic conditions, activity of the PHDs decreases, reducing recognition of HIF-a by pVHL (Chan et al., 2002; Ivan et al., 2001; Jaakkola et al., 2001).”
Self-citationCoordinate Regulation of the Oxygen-Dependent Degradation Domains of Hypoxia-Inducible Factor 1α
Chan, D. A., Sutphin, P. D., Yen, S.-E., & Giaccia, A. J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6415-6426.2005 · Cited by 240
“These data are consistent with peptide and recombinant protein studies, which demonstrated that hypoxia and agents that inhibit prolyl hydroxylation of both proline 402 and proline 564 lead to HIF-1 stabilization ( 9 , 20, 21, 33).”
BackgroundMethodResultInfluentialSelf-citationFrost, J., Galdeano, C., Soares, P., Gadd, M. S., Grzes, K. M., Ellis, L., Epemolu, O., Shimamura, S., Bantscheff, M., Grandi, P., et al. (2016) · Nature Communications · doi:10.1038/ncomms13312 · Cited by 239
Cellular oxygen sensing need in CNS function: physiological and pathological implications
Acker, T., & Acker, H. (2004) · Journal of Experimental Biology · doi:10.1242/jeb.01075 · Cited by 231
“Interestingly, PHD activity in cancer cells may be reduced, as suggested by incomplete prolyl hydroxylation of HIF-α in normoxic tissue culture as detected by hydroxylation-specific ntibodies (Chan et al., 2002).”
BackgroundRegulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases
Hirota, K., & Semenza, G. L. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.193 · Cited by 229
Baek, J. H., Mahon, P. C., Oh, J., Kelly, B., Krishnamachary, B., Pearson, M., Chan, D. A., Giaccia, A. J., & Semenza, G. L. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.01.011 · Cited by 222
Self-citationEbbesen, P., Pettersen, E. O., Gorr, T. A., Jobst, G., Williams, K., Kieninger, J., Wenger, R. H., Pastorekova, S., Dubois, L., Lambin, P., et al. (2009) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360902784425 · Cited by 218
HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O2 levels
Masson, N., & Ratcliffe, P. J. (2003) · Journal of Cell Science · doi:10.1242/jcs.00655 · Cited by 215
Regulation of HIF prolyl hydroxylases by hypoxia‐inducible factors
Aprelikova, O., Chandramouli, G. V. R., Wood, M., Vasselli, J. R., Riss, J., Maranchie, J. K., Linehan, W. M., & Barrett, J. C. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20067 · Cited by 214
“Furthermore, the introduction of oncogenic form of Ras and v-Src resulted in the stabilization of HIF-1a in normoxia and the loss of Pro 564 hydroxylation probably due to inhibition of prolyl hydroxylase [Chan et al., 2002].”
MethodThe von Hippel–Lindau protein, HIF hydroxylation, and oxygen sensing
Kaelin, W. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.165 · Cited by 214
Metabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer
Lien, E. C., Lyssiotis, C. A., & Cantley, L. C. (2016) · Recent Results in Cancer Research · doi:10.1007/978-3-319-42118-6_3 · Cited by 212
Hypoxia‐inducible factor‐1 and oncogenic signalling
Bárdos, J. I., & Ashcroft, M. (2004) · BioEssays · doi:10.1002/bies.20002 · Cited by 206
“Introduction of v-Src or Ras results in stabilisation of HIF-1a in normoxia,((30,68)) and cells that express constitutively active Src also express increased levels of HIF-1a protein under normoxic conditions,((69)) resulting in HIF-1-target gene induc-”
InfluentialThe role of p53 in hypoxia-induced apoptosis
Hammond, E. M., & Giaccia, A. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.154 · Cited by 205
Self-citationHif-1α regulates differentiation of limb bud mesenchyme and joint development
Provot, S., Zinyk, D., Gunes, Y., Kathri, R., Le, Q., Kronenberg, H. M., Johnson, R. S., Longaker, M. T., Giaccia, A. J., & Schipani, E. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200612023 · Cited by 198
“Whereas Hif-1β protein is constitutively ex pressed, Hif-1α protein is subject to rapid degradation by oxygen-dependent proteolysis (Ohh and Kaelin, 1999; Ivan et al., 2001; Jaakkola et al., 2001; Chan et al., 2002; Min et al., 2002).”
BackgroundSelf-citationThe hypoxia‐inducible‐factor hydroxylases bring fresh air into hypoxia signalling
Berra, E., Ginouvès, A., & Pouysségur, J. (2006) · EMBO reports · doi:10.1038/sj.embor.7400598 · Cited by 196
“Similarly, normoxic stabilization of HIF-1α by some oncogenes is mediated by the inhibition of prolyl hydroxylation—such as in RasVal12 and v-Src activation (Chan et al, 2002).”
BackgroundRole and regulation of autophagy in cancer
Rakesh, R., PriyaDharshini, L. C., Sakthivel, K. M., & Rasmi, R. R. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166400 · Cited by 192
Oxygen-Regulated Gene Expression in Bovine Blastocysts1
Harvey, A. J., Kind, K. L., Pantaleon, M., Armstrong, D. T., & Thompson, J. G. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.104.028639 · Cited by 189
“DFO is an iron chelator [38] that has been extensively used in HIF protein studies, as it interferes with hydroxylation of HIF protein normally required for ubiquitination targeting under normoxic conditions, thereby stabilizing HIFa subunits [20, 39, 40].”
BackgroundRedox regulation of the hypoxia-inducible factor
Pouysségur, J., & Mechta-Grigoriou, F. (2006) · Biological Chemistry · doi:10.1515/bc.2006.167 · Cited by 186
“Interestingly, it has been shown that HIF-a stabilization by these oncogenes results from inhibition of the PHD activity (Chan et al., 2002).”
BackgroundHIFs and tumors—causes and consequences
Höpfl, G., Ogunshola, O., & Gassmann, M. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00538.2003 · Cited by 185
“In one report, Ras- and v-Src-mediated HIF-1 upregulation under normoxic conditions are attributed to prolyl-hydroxylase inhibition (35), suggesting that malignant transformation could directly stabilize HIF-1 independent of VHL.”
BackgroundSutendra, G., Dromparis, P., Kinnaird, A., Stenson, T. H., Haromy, A., Parker, J. M. R., McMurtry, M. S., & Michelakis, E. D. (2013) · Oncogene · doi:10.1038/onc.2012.198 · Cited by 184
Pagé, E. L., Chan, D. A., Giaccia, A. J., Levine, M., & Richard, D. E. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-06-0612 · Cited by 181
“Anti-hydroxylated HIF-1 against hydroxylated Pro402 and hydroxylated Pro564 of the human sequence of HIF-1 were obtained as previously described (Chan et al., 2002, 2005).”
Self-citationThe subtle side to hypoxia inducible factor (HIFα) regulation
Bilton, R. L., & Booker, G. W. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03446.x · Cited by 148
The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation
Bedogni, B., Welford, S. M., Cassarino, D. S., Nickoloff, B. J., Giaccia, A. J., & Powell, M. B. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.11.005 · Cited by 179
“Ras, commonly mutated in a variety of human cancers, contributes to HIF1a stabilization by inhibiting prolyl hydroxylation ( Chan et al., 2002 ).”
BackgroundSelf-citationZhou, J., Schmid, T., & Brüne, B. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-09-0598 · Cited by 177
“Interestingly, Chan et al. (2002) reported that active Akt provoked accumulation of hydroxylated HIF-1 , most likely because of increased protein translation of decreased protein degradation.”
Serganova, I., Doubrovin, M., Vider, J., Ponomarev, V., Soghomonyan, S., Beresten, T., Ageyeva, L., Serganov, A., Cai, S., Balatoni, J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0842 · Cited by 177
HIF hydroxylation and cellular oxygen sensing
Metzen, E., & Ratcliffe, P. J. (2004) · Biological Chemistry · doi:10.1515/bc.2004.016 · Cited by 172
“Using a hydroxylation-specific HIF-1a antibody it has been shown that Akt causes accumulation of hydroxylated HIF-1a whereas v-Src and RasV12 directly or indirectly inhibit HIF-1a prolyl hydroxylation (Chan et al., 2003).”
MethodPatten, D. A., Lafleur, V. N., Robitaille, G. A., Chan, D. A., Giaccia, A. J., & Richard, D. E. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-01-0025 · Cited by 171
“To analyze HIF-1 hydroxylation status, specific antibodies against hydroxylated HIF-1 on its two key ODDD proline residues were used (Chan et al., 2002; Chan et al., 2005).”
MethodSelf-citationKoay, E. J., & Athanasiou, K. A. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2008.04.007 · Cited by 169
Maxwell, P. H. (2005) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2005.03.001 · Cited by 167
Oncogenic regulation of tumor metabolic reprogramming
Tarrado-Castellarnau, M., de Atauri, P., & Cascante, M. (2016) · Oncotarget · doi:10.18632/oncotarget.10911 · Cited by 161
“For example, induction of RAS or SRC oncogenic signaling promotes normoxic HIF1α accumulation through prolyl hydroxylation inhibition [161].”
BackgroundAdaptive Myogenesis under Hypoxia
Yun, Z., Lin, Q., & Giaccia, A. J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.8.3040-3055.2005 · Cited by 145
“To assess the role of HIF-1 in the myogenic differentiation of C2C12 myoblasts, we infected proliferating C2C12 cells with retrovirus containing an O2-insensitive and constitutively active form of HIF-1: ODD (deletion of the oxygen-dependent degradation domain) and the P402A/ P564G mutant ( 11 , 42) (Fig. 8A).”
BackgroundSelf-citationVoltage‐dependent anion channel 1 is involved in endostatin‐induced endothelial cell apoptosis
Yuan, S., Fu, Y., Wang, X., Shi, H., Huang, Y., Song, X., Li, L., Song, N., & Luo, Y. (2008) · The FASEB Journal · doi:10.1096/fj.08-107417 · Cited by 137
“Cobalt chloride (CoCl2) is known to stabilize HIF-1 by preventing the effects of VHL protein ( 40 ).”
BackgroundInvolvement of Drp1 in hypoxia-induced migration of human glioblastoma U251 cells
Wan, Y., Zhang, J., Yang, Z., Jiang, L., WEI, Y.-F., Lai, Q., WANG, J.-B., XIN, H.-B., & Han, X. (2014) · Oncology Reports · doi:10.3892/or.2014.3235 · Cited by 152
HIF-1: An Oxygen Response System with Special Relevance to the Kidney
Maxwell, P. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000092792.97122.e0 · Cited by 132
Allison, S. J., Knight, J. R. P., Granchi, C., Rani, R., Minutolo, F., Milner, J., & Phillips, R. M. (2014) · Oncogenesis · doi:10.1038/oncsis.2014.16 · Cited by 135
Oxygen and Iron Regulation of Iron Regulatory Protein 2
Hanson, E. S., Rawlins, M. L., & Leibold, E. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302798200 · Cited by 141
Han, Z.-B., Ren, H., Zhao, H., Chi, Y., Chen, K., Zhou, B., Liu, Y.-J., Zhang, L., Xu, B., Liu, B., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn066 · Cited by 133
“It has also been shown that oxygen-independent HIF-1a expression might occur by oncogene activation (44, 45 ), inactivation of tumor suppressor genes (46) and activation of growth factor signaling (22,24,39).”
BackgroundGuo, M., Song, L., Jiang, Y., Liu, W., Yu, Y., & Chen, G. (2005) · APOPTOSIS · doi:10.1007/s10495-005-3085-3 · Cited by 142
Anoxia Is Necessary for Tumor Cell Toxicity Caused by a Low-Oxygen Environment
Papandreou, I., Krishna, C., Kaper, F., Cai, D., Giaccia, A. J., & Denko, N. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3395 · Cited by 127
“(P402A/P564G) expression vector has been described (27).”
Self-citationOncogenic KRAS and BRAF Differentially Regulate Hypoxia-Inducible Factor-1α and -2α in Colon Cancer
Kikuchi, H., Pino, M. S., Zeng, M., Shirasawa, S., & Chung, D. C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2213 · Cited by 116
“Transformation by H-ras or mutant K-ras has also been shown to enhance the levels of HIF-1α protein (17, 18).”
Pfander, D., Kobayashi, T., Knight, M. C., Zelzer, E., Chan, D. A., Olsen, B. R., Giaccia, A. J., Johnson, R. S., Haase, V. H., & Schipani, E. (2004) · Development · doi:10.1242/dev.01138 · Cited by 128
“For immunoblotting, cells were lyzed, and detection of HIF1α hydroxylated at Pro564 was performed as previously described (Chan et al., 2002).”
MethodSelf-citationMitochondrial regulation of oxygen sensing
Bell, E. L., Emerling, B. M., & Chandel, N. S. (2005) · Mitochondrion · doi:10.1016/j.mito.2005.06.005 · Cited by 130
Hypoxia and HIF-1α in chondrogenesis
Schipani, E. (2005) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2005.03.003 · Cited by 129
Siddiq, A., Aminova, L. R., & Ratan, R. R. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9268-7 · Cited by 129
“Like HIF-1α, HIF-2α (also known as endothelial PAS protein-1, EPAS-1) is also upregulated by hypoxia and activates transcription via binding of hypoxia response elements (HREs) and is regulated in the same way as HIF-1 [76,83,85-88].”
BackgroundHypoxia-inducible factor-1 in tumour angiogenesis
Shi, Y., & Fang, W. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i8.1082 · Cited by 127
“Indeed, introduction of v-Src or RasV12 oncogenes resulted in stabilization of normoxic HIF-1α[17] and loss of hydroxylated-Pro-564 demonstrated that oncogenes induced stabilization of HIF-1α signals by inhibiting prolyl hydroxylation[ 13 ].”
BackgroundMethodInfluentialHIF-Dependent Hematopoietic Factors Regulate the Development of the Embryonic Vasculature
Ramírez‐Bergeron, D. L., Runge, A., Adelman, D. M., Gohil, M., & Simon, M. C. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.04.018 · Cited by 125
“However, VEGF regulation by hypoxia also includes increased mRNA translational efficiency, protein stability, and biological activity (Chan et al., 2002; Claffey et al., 1998; Stein et al, 1998).”
BackgroundTumor-induced modulation of dendritic cell function
Gottfried, E., Kreutz, M. P., & Mackensen, A. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.10.008 · Cited by 127
“[161] Chan DA, Sutphin PD, Denko NC, Giaccia AJ.”
BackgroundTanaka, H., Yamamoto, M., Hashimoto, N., Miyakoshi, M., Tamakawa, S., Yoshie, M., Tokusashi, Y., Yokoyama, K., Yaginuma, Y., & Ogawa, K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1699 · Cited by 107
SATO, H., SATO, M., KANAI, H., UCHIYAMA, T., ISO, T., OHYAMA, Y., SAKAMOTO, H., TAMURA, J., NAGAI, R., & KURABAYASHI, M. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.04.017 · Cited by 106
“demonstrated that HIF-1a could be stabilized by oncogenic stimuli including v-Src expression via inhibition of a prolyl hydroxylation event [24].”
BackgroundNovel Angiogenic Signaling Pathways and Vascular Targets
Bicknell, R., & Harris, A. L. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121650 · Cited by 111
Mayer, A., Wree, A., Höckel, M., Leo, C., Pilch, H., & Vaupel, P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3566 · Cited by 101
Hypoxia attenuates the p53 response to cellular damage
Achison, M., & Hupp, T. R. (2003) · Oncogene · doi:10.1038/sj.onc.1206434 · Cited by 107
Jokilehto, T., Rantanen, K., Luukkaa, M., Heikkinen, P. T., Grenman, R. A., Minn, H. R. I., Kronqvist, P., & Jaakkola, P. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2022 · Cited by 106
Zhang, Y., Liu, Q., Wang, F., Ling, E., Liu, S., Wang, L., Yang, Y., Yao, L., Chen, X., Wang, F., et al. (2013) · Journal of Pineal Research · doi:10.1111/jpi.12052 · Cited by 105
Mitochondrial Regulation of Oxygen Sensing
Chandel, N. S. (2010) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-60761-500-2_22 · Cited by 91
Short Hairpin RNA Interference Therapy for Ischemic Heart Disease
Huang, M., Chan, D. A., Jia, F., Xie, X., Li, Z., Hoyt, G. E., Robbins, R. C., Chen, X. S., Giaccia, A. J., & Wu, J. C. (2008) · Circulation · doi:10.1161/circulationaha.107.760785 · Cited by 103
Self-citationCrisóstomo, L., Alves, M. G., Gorga, A., Sousa, M., Riera, M. F., Galardo, M. N., Meroni, S. B., & Oliveira, P. F. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7698-0_11 · Cited by 102
Han, J.-Y., Oh, S. H., Morgillo, F., Myers, J. N., Kim, E., Hong, W. K., & Lee, H.-Y. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji251 · Cited by 99
Knowles, H. J., & Athanasou, N. (2008) · The Journal of Pathology · doi:10.1002/path.2319 · Cited by 96
“For example src- and ras-induced HIF-1α is non-hydroxylated [14], suggesting inhibition of PHD enzyme activity, whereas enhanced HIF1α translation by insulin [15] or hepatocyte growth factor (HGF) [16] might present an increased substrate load exceeding PHD enzyme capacity.”
BackgroundAkt and Hypoxia-Inducible Factor-1 Independently Enhance Tumor Growth and Angiogenesis
Arsham, A. M., Plas, D. R., Thompson, C. B., & Simon, M. C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2239 · Cited by 88
“Although activation of the PI3K/Akt pathway can lead to increased HIF-1 (3), this induction is generally of a lower magnitude than hypoxia itself and appears to be through a distinct, hydroxylation- and pVHLindependent mechanism ( 68 ) involving increased translation (69).”
BackgroundInhibition of VEGF blocks TGF-β1production through a PI3K/Akt signalling pathway
Lee, K. S., Park, S. J., Kim, S. R., Min, K. H., Lee, K. Y., Choe, Y. H., Hong, S. H., Lee, Y. R., Kim, J. S., Hong, S. J., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00125007 · Cited by 90
“In addition, several studies have demonstrated that activation of the PI3K/Akt pathway causes the increase of HIF-1a protein levels [ 38 ].”
Background
Metadata
- Authors
- Chan, D. A., Sutphin, P. D., Denko, N. C., & Giaccia, A. J.
- Affiliations
- Stanford University (US)
- Corresponding author
- Giaccia, Amato J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-10
- Volume
- 277
- Issue
- 42
- Pages
- 40112-40117
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2044030331
- Cited by
- 264
- References
- 25
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 4 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 6 · 2017: 4 · 2016: 8 · 2015: 9 · 2014: 9 · 2013: 16 · 2012: 9
- FWCI
- 11.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6590 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA67166)
- National Cancer Institute (P01CA067166, CA09302, CA 67166, T32CA009302)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Keywords
- prolyl hydroxylation, hypoxia-inducible factor-1α, HIF-2α, HIF-1α stabilization, VHL, E3 ubiquitin ligase, post-translational modification, normoxia, oncogenic Ras, v-Src, deferoxamine, cobalt chloride
- MeSH terms
- Amino Acids, Dicarboxylic, Animals, Hypoxia, Chelating Agents, Cobalt, Deferoxamine, Fibroblasts, Hydroxylation, Iron, Luciferases, Proline, Protein Binding, Transcription Factors, Transfection, Immunoblotting, Mice, Knockout, Mice, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.